# Monopar Therapeutics: Form 10-K/A for the period ended Dec 31, 2025

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: 10-K/A
- Filed: 2026-04-01
- Accepted by EDGAR: Apr 1, 2026, 12:24 ET
- Period: 2025-12-31
- Accession: 0001437749-26-010841
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010841/mnpr20251231c_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010841/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774926010841/mnpr20251231c_10ka.htm

Filed Apr 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-010841. Last ingested by Listed: Nov 4, 2026, 20:49 ET. No prices; not investment advice.